s3-e41.6 - from the vault: why nash drug trials fail
Published 2 years ago • 83 plays • Length 17:52Download video MP4
Download video MP3
Similar videos
-
1:00:30
s3-e38.1 - from the vault: why nash drug trials fail
-
1:00:30
s3-e38.1 - looking back through the vault: why nash drug trials fail
-
15:12
s4-e41.6 - from the vault: highlights from paris nash 2021
-
15:07
s5 - e4.6 - from the vault: what a nash disease model reveals about treating advanced fibrosis
-
12:02
s3-e41.1 - improving nash clinical trials by reducing screen fail rates
-
15:04
s4-e36.6 - from the vault: nash challenges: early diagnosis & nash patient management
-
16:21
s3-e55.6 - from the vault: #nashday 2022 wrap-up panel: the importance of #stopnashnow
-
13:30
s4-e42.6 - from the vault: nafld summit in context and learning from failed trials
-
9:06
you can't be good at everything, can you? | grant noble
-
9:31
griffin colapinto unleashes the beast (with a helmet for protection) | first & last
-
20:15
kolohe and griffin's first time to waco! | lost surfboards team x the bsr pool
-
12:31
s3-e41.5 - improving nash clinical trials by reducing screen fail rates
-
48:30
clinical overview of nafl/nash
-
12:45
s3-e41.4 - improving nash clinical trials by reducing screen fail rates
-
13:51
s4-e15.5 - from the vault: advancing nash best practices in nits: “stacking” nash biomarkers
-
58:17
ask the experts: nash and clinical trials
-
2:11
transforming nash clinical trials with aim-nash
-
13:22
s4-e12.6 - from the vault: building a disease model for nash prevalence: key challenges
-
1:36:27
from the vault: future nash drug development: more diverse trial populations and more study of comb
-
3:42
the archives | surfer vol. 3, issue one
-
1:59
win 3 lost surfboards by judging surf100!
-
2:24
nash is a "silent" liver disease